Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR
Stopped early
Conditions studied: Hydrops Fetalis, Fetal Growth Retardation
In brief
The objective of this pilot study is to prospectively evaluate amniotic fluid of pregnancies complicated by non-immune hydrops and severe symmetrical intrauterine growth restriction by tandem mass spectrometry for inborn errors of metabolism.
Key facts
- Study ID
- NCT00143039
- Run by
- Obstetrix Medical Group
- People needed
- 48
- Starts
- 2006-03-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2014-12-19
Who can join
Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Banner Good Sammaritan Hospital — Phoenix, Arizona, United States
- Banner Desert Samaritan Hospital — Phoenix, Arizona, United States
- Saddleback Memorial Medical Center — Laguna Hills, California, United States
- Long Beach Memorial Medical Center — Long Beach, California, United States
- Good Samaritan Hospital — San Jose, California, United States
- Swedish Medical Center — Denver, Colorado, United States
- Presbyterian/St Luke's Hospital — Denver, Colorado, United States
- DeKalb Medical Center — Decatur, Georgia, United States
- Southern Regional Medical Center — Riverdale, Georgia, United States
- Harris Methodist Fort Worth Hospital — Fort Worth, Texas, United States
- Swedish Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.